- Book
- August 2022
- 496 Pages
- Book
- July 2022
- 880 Pages
- Book
- November 2020
- 574 Pages
- Book
- October 2020
- 800 Pages
- Book
- April 2019
- 392 Pages
- Book
- April 2019
- 1008 Pages
- Book
- April 2019
- 328 Pages
- Book
- February 2011
- 488 Pages
- Book
- April 2024
- 1280 Pages
- Book
- August 2018
- 376 Pages
- Book
- May 2016
- 512 Pages
- Book
- January 2016
- 288 Pages
- Book
- March 2015
- 512 Pages
- Book
- January 2013
- 304 Pages
- Book
- October 2012
- 330 Pages
Global
- Book
- December 2011
- 628 Pages
- Book
- October 2011
- 360 Pages
Europe
- Book
- April 2011
- 248 Pages
Global
- Book
- October 2010
- 200 Pages

Stroke is a medical condition that occurs when the blood supply to the brain is interrupted, resulting in the death of brain cells. It is the leading cause of disability and the fifth leading cause of death in the United States. Cardiology is the branch of medicine that deals with the diagnosis and treatment of diseases of the heart and blood vessels. Stroke is a major focus of cardiology, as it is a major cause of death and disability.
Stroke is a major focus of cardiology research, with a variety of treatments and therapies being developed to reduce the risk of stroke and improve outcomes for those who have suffered a stroke. There are a number of companies that are involved in the development and delivery of stroke treatments and therapies, including pharmaceutical companies, medical device companies, and biotechnology companies. Examples of companies in the stroke market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more